ID

43903

Descripción

Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM; ODM derived from: https://clinicaltrials.gov/show/NCT02301806

Link

https://clinicaltrials.gov/show/NCT02301806

Palabras clave

Versiones (2)
  1. 29/6/16 29/6/16 -
  2. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes NCT02301806

Inglés

Eligibility Type 2 Diabetes NCT02301806

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent before any study specific procedures
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
type ii diabetes who have inadequate glycaemic control (6.5%≦hba1c＜9.0%)
Descripción

Diabetes Mellitus, Non-Insulin-Dependent Poor glycemic control

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0342299
age from 20 to 80 years old
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
no history of using any antihyperglycemic drugs
Descripción

Hypoglycemic Agents Not used

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020616
UMLS CUI [1,2]
C0445107
no history of cardiovascular complications
Descripción

Cardiac complication Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0161816
UMLS CUI [1,2]
C0332197
no treatment or treatment with stable doses of lipid-lowering, antihypertensive, and antiplatelet agents for at least 3 months prior to randomization
Descripción

Antilipemic agent Therapeutic procedure Absent | Antilipemic agent Therapeutic procedure Dosage Stable | Antihypertensive Agents Therapeutic procedure Absent | Antihypertensive Agents Therapeutic procedure Dosage Stable | Antiplatelet Agents Therapeutic procedure Absent | Antiplatelet Agents Therapeutic procedure Dosage Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0086440
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0086440
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C0205360
UMLS CUI [3,1]
C0003364
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0003364
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0178602
UMLS CUI [4,4]
C0205360
UMLS CUI [5,1]
C0085826
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C0332197
UMLS CUI [6,1]
C0085826
UMLS CUI [6,2]
C0087111
UMLS CUI [6,3]
C0178602
UMLS CUI [6,4]
C0205360
4.5 % ≤ fasting fmd at baseline < 8.0 %
Descripción

Diet therapy Fasting Imitation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012159
UMLS CUI [1,2]
C0015663
UMLS CUI [1,3]
C3826143
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
・type i diabetes
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
liver disease (hepatic enzymes more than three times the upper limit of normal ranges)
Descripción

Liver disease Elevated liver enzymes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0235996
impairared kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women)
Descripción

Renal Insufficiency | Creatinine measurement, serum | Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0079399
cigarette smokers
Descripción

Cigarette smoker

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0337667
contraindications to glimepiride and sitagliptin
Descripción

Medical contraindication glimepiride | Medical contraindication sitagliptin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0061323
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1565750
active proliferative diabetic retinopathy
Descripción

Proliferative diabetic retinopathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0154830
Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes NCT02301806

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
provision of informed consent before any study specific procedures
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent Poor glycemic control
Item
type ii diabetes who have inadequate glycaemic control (6.5%≦hba1c＜9.0%)
boolean
C0011860 (UMLS CUI [1,1])
C0342299 (UMLS CUI [1,2])
Age
Item
age from 20 to 80 years old
boolean
C0001779 (UMLS CUI [1])
Hypoglycemic Agents Not used
Item
no history of using any antihyperglycemic drugs
boolean
C0020616 (UMLS CUI [1,1])
C0445107 (UMLS CUI [1,2])
Cardiac complication Absent
Item
no history of cardiovascular complications
boolean
C0161816 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Antilipemic agent Therapeutic procedure Absent | Antilipemic agent Therapeutic procedure Dosage Stable | Antihypertensive Agents Therapeutic procedure Absent | Antihypertensive Agents Therapeutic procedure Dosage Stable | Antiplatelet Agents Therapeutic procedure Absent | Antiplatelet Agents Therapeutic procedure Dosage Stable
Item
no treatment or treatment with stable doses of lipid-lowering, antihypertensive, and antiplatelet agents for at least 3 months prior to randomization
boolean
C0086440 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0086440 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0003364 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0003364 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C0205360 (UMLS CUI [4,4])
C0085826 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0085826 (UMLS CUI [6,1])
C0087111 (UMLS CUI [6,2])
C0178602 (UMLS CUI [6,3])
C0205360 (UMLS CUI [6,4])
Diet therapy Fasting Imitation
Item
4.5 % ≤ fasting fmd at baseline < 8.0 %
boolean
C0012159 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
C3826143 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
・type i diabetes
boolean
C0011854 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Liver disease Elevated liver enzymes
Item
liver disease (hepatic enzymes more than three times the upper limit of normal ranges)
boolean
C0023895 (UMLS CUI [1,1])
C0235996 (UMLS CUI [1,2])
Renal Insufficiency | Creatinine measurement, serum | Gender
Item
impairared kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Cigarette smoker
Item
cigarette smokers
boolean
C0337667 (UMLS CUI [1])
Medical contraindication glimepiride | Medical contraindication sitagliptin
Item
contraindications to glimepiride and sitagliptin
boolean
C1301624 (UMLS CUI [1,1])
C0061323 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1565750 (UMLS CUI [2,2])
Proliferative diabetic retinopathy
Item
active proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial